JP5039695B2 - 胸部体液蓄積の予測 - Google Patents
胸部体液蓄積の予測 Download PDFInfo
- Publication number
- JP5039695B2 JP5039695B2 JP2008513627A JP2008513627A JP5039695B2 JP 5039695 B2 JP5039695 B2 JP 5039695B2 JP 2008513627 A JP2008513627 A JP 2008513627A JP 2008513627 A JP2008513627 A JP 2008513627A JP 5039695 B2 JP5039695 B2 JP 5039695B2
- Authority
- JP
- Japan
- Prior art keywords
- fluid accumulation
- thoracic fluid
- parameter
- patient
- impending
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012530 fluid Substances 0.000 title claims description 292
- 238000009825 accumulation Methods 0.000 title claims description 284
- 210000000115 thoracic cavity Anatomy 0.000 title claims description 275
- 238000011282 treatment Methods 0.000 claims description 66
- 210000002216 heart Anatomy 0.000 claims description 43
- 229940079593 drug Drugs 0.000 claims description 29
- 210000004369 blood Anatomy 0.000 claims description 28
- 239000008280 blood Substances 0.000 claims description 28
- 239000003814 drug Substances 0.000 claims description 28
- 230000001225 therapeutic effect Effects 0.000 claims description 24
- 230000000747 cardiac effect Effects 0.000 claims description 23
- 230000007613 environmental effect Effects 0.000 claims description 23
- 230000000875 corresponding effect Effects 0.000 claims description 18
- 238000009125 cardiac resynchronization therapy Methods 0.000 claims description 14
- 206010003119 arrhythmia Diseases 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000002685 pulmonary effect Effects 0.000 claims description 8
- 206010011224 Cough Diseases 0.000 claims description 7
- 230000002596 correlated effect Effects 0.000 claims description 7
- 235000005911 diet Nutrition 0.000 claims description 7
- 230000000241 respiratory effect Effects 0.000 claims description 6
- 230000036387 respiratory rate Effects 0.000 claims description 6
- 230000037213 diet Effects 0.000 claims description 5
- 239000003792 electrolyte Substances 0.000 claims description 5
- 210000005242 cardiac chamber Anatomy 0.000 claims description 4
- 230000002644 neurohormonal effect Effects 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 208000019116 sleep disease Diseases 0.000 claims description 2
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 238000009423 ventilation Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 31
- 238000002560 therapeutic procedure Methods 0.000 description 19
- 238000010586 diagram Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 230000029058 respiratory gaseous exchange Effects 0.000 description 12
- 206010019280 Heart failures Diseases 0.000 description 11
- 210000000038 chest Anatomy 0.000 description 11
- 238000007726 management method Methods 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- 230000033764 rhythmic process Effects 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 230000002861 ventricular Effects 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 230000001746 atrial effect Effects 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 206010037423 Pulmonary oedema Diseases 0.000 description 6
- 208000005333 pulmonary edema Diseases 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 208000002151 Pleural effusion Diseases 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 230000028161 membrane depolarization Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 210000005245 right atrium Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010007559 Cardiac failure congestive Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000002876 beta blocker Substances 0.000 description 3
- 229940097320 beta blocking agent Drugs 0.000 description 3
- 238000013194 cardioversion Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- 241000208011 Digitalis Species 0.000 description 2
- 206010013974 Dyspnoea paroxysmal nocturnal Diseases 0.000 description 2
- 208000004327 Paroxysmal Dyspnea Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000028831 congenital heart disease Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 238000002489 impedance cardiography Methods 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004115 mitral valve Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 210000004224 pleura Anatomy 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 101800001144 Arg-vasopressin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 208000021908 Myocardial disease Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000009118 appropriate response Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000005244 lower chamber Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
- 108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000004213 regulation of atrial cardiomyocyte membrane depolarization Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N2001/0585—Coronary sinus electrodes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/136,195 | 2005-05-24 | ||
| US11/136,195 US8900154B2 (en) | 2005-05-24 | 2005-05-24 | Prediction of thoracic fluid accumulation |
| PCT/US2006/019937 WO2006127719A2 (en) | 2005-05-24 | 2006-05-23 | Prediction of thoracic fluid accumulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008545471A JP2008545471A (ja) | 2008-12-18 |
| JP2008545471A5 JP2008545471A5 (enExample) | 2009-07-16 |
| JP5039695B2 true JP5039695B2 (ja) | 2012-10-03 |
Family
ID=37192443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513627A Expired - Fee Related JP5039695B2 (ja) | 2005-05-24 | 2006-05-23 | 胸部体液蓄積の予測 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8900154B2 (enExample) |
| EP (1) | EP1904163B1 (enExample) |
| JP (1) | JP5039695B2 (enExample) |
| WO (1) | WO2006127719A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7433853B2 (en) | 2004-07-12 | 2008-10-07 | Cardiac Pacemakers, Inc. | Expert system for patient medical information analysis |
| US8900154B2 (en) | 2005-05-24 | 2014-12-02 | Cardiac Pacemakers, Inc. | Prediction of thoracic fluid accumulation |
| EP2449964B1 (en) * | 2005-07-01 | 2016-08-10 | Impedimed Limited | Connector for Impedance Measurement System |
| US7713213B2 (en) * | 2006-03-13 | 2010-05-11 | Cardiac Pacemakers, Inc. | Physiological event detection systems and methods |
| US8005543B2 (en) | 2006-05-08 | 2011-08-23 | Cardiac Pacemakers, Inc. | Heart failure management system |
| US8948868B2 (en) | 2006-10-31 | 2015-02-03 | Medtronic, Inc. | Methods and apparatus for manually suspending intrathoracic impedance fluid status measurements |
| US20080200802A1 (en) * | 2006-12-07 | 2008-08-21 | Philometron, Inc. | Platform for detection of tissue content and/or structural changes with closed-loop control in mammalian organisms |
| US7629889B2 (en) | 2006-12-27 | 2009-12-08 | Cardiac Pacemakers, Inc. | Within-patient algorithm to predict heart failure decompensation |
| US9968266B2 (en) | 2006-12-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Risk stratification based heart failure detection algorithm |
| US9022930B2 (en) * | 2006-12-27 | 2015-05-05 | Cardiac Pacemakers, Inc. | Inter-relation between within-patient decompensation detection algorithm and between-patient stratifier to manage HF patients in a more efficient manner |
| US8768718B2 (en) * | 2006-12-27 | 2014-07-01 | Cardiac Pacemakers, Inc. | Between-patient comparisons for risk stratification of future heart failure decompensation |
| US8209033B2 (en) * | 2007-05-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Method and apparatus for regulating blood volume using volume receptor stimulation |
| US8221323B2 (en) | 2007-08-03 | 2012-07-17 | Cardiac Pacemakers, Inc. | Using acoustic energy to compute a lung edema fluid status indication |
| WO2009036329A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Multi-sensor patient monitor to detect impending cardiac decompensation |
| WO2009036316A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Energy management, tracking and security for adherent patient monitor |
| US20090076345A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Device with Multiple Physiological Sensors |
| EP2194858B1 (en) | 2007-09-14 | 2017-11-22 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
| US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
| US8591430B2 (en) | 2007-09-14 | 2013-11-26 | Corventis, Inc. | Adherent device for respiratory monitoring |
| US9186089B2 (en) | 2007-09-14 | 2015-11-17 | Medtronic Monitoring, Inc. | Injectable physiological monitoring system |
| WO2009091239A1 (en) * | 2008-01-15 | 2009-07-23 | Erasmus University Medical Center Rotterdam | System and method for monitoring pressure within a living body |
| JP5405500B2 (ja) | 2008-03-12 | 2014-02-05 | コーヴェンティス,インク. | 心調律に基づく心代償不全予測 |
| WO2009146214A1 (en) | 2008-04-18 | 2009-12-03 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
| CN102065754A (zh) | 2008-04-21 | 2011-05-18 | 善量有限公司 | 代谢能量监控系统 |
| US8989837B2 (en) | 2009-12-01 | 2015-03-24 | Kyma Medical Technologies Ltd. | Methods and systems for determining fluid content of tissue |
| US9775987B2 (en) | 2008-10-31 | 2017-10-03 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8452394B2 (en) * | 2008-10-31 | 2013-05-28 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8823490B2 (en) | 2008-12-15 | 2014-09-02 | Corventis, Inc. | Patient monitoring systems and methods |
| WO2011050283A2 (en) | 2009-10-22 | 2011-04-28 | Corventis, Inc. | Remote detection and monitoring of functional chronotropic incompetence |
| US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
| US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
| CA2805946A1 (en) | 2010-07-21 | 2012-01-26 | Kyma Medical Technologies Ltd. | Implantable radio-frequency sensor |
| US8428720B2 (en) | 2010-10-29 | 2013-04-23 | Medtronic, Inc. | Posture-induced changes to physiological parameters |
| JP2015511843A (ja) * | 2012-02-15 | 2015-04-23 | キマ メディカル テクノロジーズ リミテッド | 監視および診断システムおよび方法 |
| JP6309096B2 (ja) | 2013-10-29 | 2018-04-11 | キマ メディカル テクノロジーズ リミテッド | アンテナシステムおよびデバイス、およびそれらの製造方法 |
| EP4233711A3 (en) | 2014-02-05 | 2023-10-18 | Zoll Medical Israel Ltd. | Apparatuses for determining blood pressure |
| US11259715B2 (en) | 2014-09-08 | 2022-03-01 | Zoll Medical Israel Ltd. | Monitoring and diagnostics systems and methods |
| US10548485B2 (en) | 2015-01-12 | 2020-02-04 | Zoll Medical Israel Ltd. | Systems, apparatuses and methods for radio frequency-based attachment sensing |
| EP4445834A3 (en) | 2017-04-29 | 2024-12-25 | Cardiac Pacemakers, Inc. | Heart failure event rate assessment |
| EP3664694B1 (en) | 2017-08-10 | 2025-12-10 | ZOLL Medical Israel Ltd. | System for physiological monitoring of patients |
| EP3840654B1 (en) | 2018-08-20 | 2025-04-23 | Thomas Jefferson University | Acoustic sensor and ventilation monitoring system |
| US11213225B2 (en) | 2018-08-20 | 2022-01-04 | Thomas Jefferson University | Acoustic sensor and ventilation monitoring system |
| US11000191B2 (en) | 2018-08-20 | 2021-05-11 | Thomas Jefferson University | Acoustic sensor and ventilation monitoring system |
| US20200196944A1 (en) * | 2018-12-21 | 2020-06-25 | W. L. Gore & Associates, Inc. | Implantable cardiac sensors |
| CN120381302B (zh) * | 2025-06-27 | 2025-09-30 | 国家心血管病中心 | 适用于超声引导介入手术机器人的超声图像处理装置及方法 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4059169A (en) | 1976-02-09 | 1977-11-22 | Hagen Winston H | Monitor for biological volume changes |
| US4686987A (en) | 1981-06-18 | 1987-08-18 | Cardiac Pacemakers, Inc. | Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiologic demand |
| IT1156564B (it) | 1982-03-16 | 1987-02-04 | Gianni Plicchi | Elettrostimolatore cardiaco impiantabile, di tipo fisiologico, in cui la frequenza di stimolazione e'regolata dalla frequenza respiratoria del paziente |
| US4450527A (en) | 1982-06-29 | 1984-05-22 | Bomed Medical Mfg. Ltd. | Noninvasive continuous cardiac output monitor |
| US4576183A (en) | 1983-09-21 | 1986-03-18 | Gianni Plicchi | Electronic circuit for monitoring respiratory parameter for controlling operation of implantable medical device |
| DE3732640C1 (de) | 1987-09-28 | 1989-05-18 | Alt Eckhard | Medizinisches Geraet zum Ermitteln von physiologischen Funktionsparametern |
| CA2033765C (en) | 1990-03-08 | 1999-10-19 | Brian D. Pederson | Variation in cardiac chamber volume or pressure as a controlling parameter |
| US5036849A (en) | 1990-04-04 | 1991-08-06 | Cardiac Pacemakers, Inc. | Variable rate cardiac pacer |
| SE9101276D0 (sv) | 1991-04-26 | 1991-04-26 | Siemens Elema Ab | Implanterbar medicinsk anordning |
| US5282840A (en) | 1992-03-26 | 1994-02-01 | Medtronic, Inc. | Multiple frequency impedance measurement system |
| US5735284A (en) | 1992-06-24 | 1998-04-07 | N.I. Medical Ltd. | Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body |
| EP0584388B1 (de) | 1992-08-26 | 1998-07-08 | Pacesetter AB | Herzschrittmacher zum Erzeugen eines dem Atemzeitvolumen eines Patienten entsprechenden Signals |
| SE9300282D0 (sv) | 1993-01-29 | 1993-01-29 | Siemens Elema Ab | Foerfarande och anordning foer att maeta floedet av en elektrolytisk vaetska |
| US5404877A (en) | 1993-06-04 | 1995-04-11 | Telectronics Pacing Systems, Inc. | Leadless implantable sensor assembly and a cardiac emergency warning alarm |
| US5454377A (en) | 1993-10-08 | 1995-10-03 | The Ohio State University | Method for measuring the myocardial electrical impedance spectrum |
| FR2714611B1 (fr) | 1993-12-31 | 1996-03-15 | Ela Medical Sa | Procédé de contrôle d'un dispositif implantable actif. |
| US5562712A (en) | 1994-11-25 | 1996-10-08 | Dow Corning Corporation | Minute volume rate-responsive pacemaker using dual unipolar leads |
| US5507785A (en) | 1994-12-21 | 1996-04-16 | Intermedics, Inc. | Rate responsive cardiac pacemaker with biphasic impedance sensing and method |
| US5876353A (en) | 1997-01-31 | 1999-03-02 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
| US5957861A (en) | 1997-01-31 | 1999-09-28 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
| US5788643A (en) | 1997-04-22 | 1998-08-04 | Zymed Medical Instrumentation, Inc. | Process for monitoring patients with chronic congestive heart failure |
| US6010454A (en) * | 1997-05-29 | 2000-01-04 | Aquintel, Inc. | Fluid and electrolyte balance monitoring system for surgical and critically ill patients |
| US6314322B1 (en) | 1998-03-02 | 2001-11-06 | Abiomed, Inc. | System and method for treating dilated cardiomyopathy using end diastolic volume (EDV) sensing |
| US6104949A (en) | 1998-09-09 | 2000-08-15 | Vitatron Medical, B.V. | Medical device |
| US6473640B1 (en) | 1999-01-25 | 2002-10-29 | Jay Erlebacher | Implantable device and method for long-term detection and monitoring of congestive heart failure |
| US6512949B1 (en) | 1999-07-12 | 2003-01-28 | Medtronic, Inc. | Implantable medical device for measuring time varying physiologic conditions especially edema and for responding thereto |
| US6221011B1 (en) | 1999-07-26 | 2001-04-24 | Cardiac Intelligence Corporation | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
| US7127290B2 (en) | 1999-10-01 | 2006-10-24 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods predicting congestive heart failure status |
| US6678547B2 (en) | 2001-03-08 | 2004-01-13 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system using time-domain heart rate variability indicia |
| US6272377B1 (en) | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
| US6409675B1 (en) * | 1999-11-10 | 2002-06-25 | Pacesetter, Inc. | Extravascular hemodynamic monitor |
| US6600949B1 (en) | 1999-11-10 | 2003-07-29 | Pacesetter, Inc. | Method for monitoring heart failure via respiratory patterns |
| US6336903B1 (en) | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
| US6752765B1 (en) | 1999-12-01 | 2004-06-22 | Medtronic, Inc. | Method and apparatus for monitoring heart rate and abnormal respiration |
| US6328699B1 (en) * | 2000-01-11 | 2001-12-11 | Cedars-Sinai Medical Center | Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure |
| JP2001198098A (ja) | 2000-01-21 | 2001-07-24 | Tanita Corp | むくみ測定方法及びむくみ測定装置 |
| US6406422B1 (en) * | 2000-03-02 | 2002-06-18 | Levram Medical Devices, Ltd. | Ventricular-assist method and apparatus |
| US7244701B2 (en) * | 2000-06-16 | 2007-07-17 | Zealand Phama A/S | Diuretic peptide conjugate |
| JP3699640B2 (ja) | 2000-08-01 | 2005-09-28 | 株式会社タニタ | 多周波生体インピーダンス測定による体水分量状態判定装置 |
| ITBO20010110A1 (it) | 2001-03-01 | 2002-09-01 | Tre Esse Progettazione Biomedi | Procedimento e dispositivo impiantabile per la misura intrapolmonare di proprieta' fisiche del tessuto polmonare dipendenti dalla sua densit |
| US6665564B2 (en) | 2001-05-21 | 2003-12-16 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system selecting A-V delay based on interval between atrial depolarization and mitral valve closure |
| US6595927B2 (en) | 2001-07-23 | 2003-07-22 | Medtronic, Inc. | Method and system for diagnosing and administering therapy of pulmonary congestion |
| US7191000B2 (en) | 2001-07-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system for edema |
| DE10148440A1 (de) | 2001-10-01 | 2003-04-17 | Inflow Dynamics Inc | Vorrichtung zum Überwachen eines Blutstaus im Herzen |
| US20050137480A1 (en) | 2001-10-01 | 2005-06-23 | Eckhard Alt | Remote control of implantable device through medical implant communication service band |
| US8777851B2 (en) | 2001-10-01 | 2014-07-15 | Medtronic, Inc. | Congestive heart failure monitor and ventilation measuring implant |
| US20030130588A1 (en) | 2002-01-10 | 2003-07-10 | Igal Kushnir | Method and system for analyzing respiratory tract sounds |
| US6963777B2 (en) | 2002-03-13 | 2005-11-08 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system and method using time between mitral valve closure and aortic ejection |
| US7226422B2 (en) | 2002-10-09 | 2007-06-05 | Cardiac Pacemakers, Inc. | Detection of congestion from monitoring patient response to a recumbent position |
| US7313434B2 (en) | 2002-11-25 | 2007-12-25 | Regents Of The University Of Minnesota | Impedance monitoring for detecting pulmonary edema and thoracic congestion |
| US7986994B2 (en) | 2002-12-04 | 2011-07-26 | Medtronic, Inc. | Method and apparatus for detecting change in intrathoracic electrical impedance |
| US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
| US7149573B2 (en) | 2003-04-25 | 2006-12-12 | Medtronic, Inc. | Method and apparatus for impedance signal localizations from implanted devices |
| US7130678B2 (en) | 2003-04-25 | 2006-10-31 | Medtronic, Inc. | Adaptive memory prioritization for implanted medical devices |
| JP2007503286A (ja) * | 2003-05-13 | 2007-02-22 | サバコア インコーポレイテッド | 心臓血管疾患を検知、診断および治療するためのシステムおよび方法 |
| US7186220B2 (en) | 2003-07-02 | 2007-03-06 | Cardiac Pacemakers, Inc. | Implantable devices and methods using frequency-domain analysis of thoracic signal |
| JP5449647B2 (ja) * | 2003-08-20 | 2014-03-19 | フィロメトロン,インコーポレイティド | ハイドレーションモニタリング |
| US8428717B2 (en) | 2003-10-14 | 2013-04-23 | Medtronic, Inc. | Method and apparatus for monitoring tissue fluid content for use in an implantable cardiac device |
| US8467876B2 (en) * | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
| US7314451B2 (en) * | 2005-04-25 | 2008-01-01 | Earlysense Ltd. | Techniques for prediction and monitoring of clinical episodes |
| US20060116590A1 (en) * | 2004-11-30 | 2006-06-01 | Pacesetter, Inc. | Endocardial pressure differential sensing systems and methods |
| US8900154B2 (en) | 2005-05-24 | 2014-12-02 | Cardiac Pacemakers, Inc. | Prediction of thoracic fluid accumulation |
-
2005
- 2005-05-24 US US11/136,195 patent/US8900154B2/en active Active
-
2006
- 2006-05-23 WO PCT/US2006/019937 patent/WO2006127719A2/en not_active Ceased
- 2006-05-23 JP JP2008513627A patent/JP5039695B2/ja not_active Expired - Fee Related
- 2006-05-23 EP EP06760306.8A patent/EP1904163B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006127719A2 (en) | 2006-11-30 |
| US8900154B2 (en) | 2014-12-02 |
| WO2006127719A3 (en) | 2007-01-25 |
| US20060271116A1 (en) | 2006-11-30 |
| JP2008545471A (ja) | 2008-12-18 |
| EP1904163B1 (en) | 2017-05-10 |
| EP1904163A2 (en) | 2008-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5039695B2 (ja) | 胸部体液蓄積の予測 | |
| US8343049B2 (en) | Physiological response to posture change | |
| US8483818B2 (en) | Enhancements to the detection of pulmonary edema when using transthoracic impedance | |
| US8805493B2 (en) | Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device | |
| US9089275B2 (en) | Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance | |
| JP4602764B2 (ja) | うっ血性心不全を予測するシステム | |
| US9943234B2 (en) | Using respiration distress manifestations for heart failure detection | |
| US8738119B2 (en) | Multi-sensor strategy for heart failure patient management | |
| US8838245B2 (en) | Respiratory stimulation for treating periodic breathing | |
| US9737720B2 (en) | Cardiac pacemaker and uses thereof | |
| JP2009517187A (ja) | 呼吸障害指数に基づいて心不全状態を評価する方法及びシステム | |
| EP2707086B1 (en) | Modifying breathing rate using a cardiac pacing device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090306 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090306 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090522 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090522 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090724 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110829 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111124 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111201 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120229 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120618 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120709 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150713 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5039695 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |